Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioRestore is a Swiss medical technology company dedicated to treating chronic low back pain caused by degenerative disc disease. The company has developed a proprietary, minimally invasive procedure that uses a specialized medical device to deliver a biological treatment directly into the intervertebral disc. This approach aims to restore the disc's structural integrity and biological function, providing a long-term solution for patients who have failed conservative treatments. BioRestore's technology represents a shift from symptomatic management to regenerative therapy in the field of orthopedics. The company is currently focused on clinical validation and scaling its regenerative platform to address a significant unmet need in spinal care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on bioRestore.